Granules India Limited's Unit V facility in Visakhapatnam has received commendation from the US Food and Drug Administration (FDA) after undergoing inspection without any observations. The inspection, which took place from April 8 to 12, 2024, focused on Active Pharmaceutical Ingredients (APIs).